Antibiotic resistance is a threat to the vision to eradicate tuberculosis (TB) by 2035. The…
IT SynapseSeptember 23, 2024
The article ‘How partnerships are driving new treatments for tuberculosis’ has just been published on World…
Andrea GarciaSeptember 21, 2022
TBAJ-587-CL-001 is the first Phase 1 trial in humans conducted by TB Alliance through the…
Inari SoininenNovember 26, 2021
An estimated 1.4 million fewer people received care for tuberculosis (TB) in 2020 than in…
Inari SoininenMarch 26, 2021
Innovative Medicines Initiative Launches European Regimen Accelerator For Tuberculosis (ERA4TB) project.
adminJanuary 29, 2020
Know how accelerate the development of new treatment regimens for tuberculosis, discover our project
The Project
